Implantable Device Arrhythmia Classification via Impedance Timing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable medical devices (IMDs) often deliver unnecessary defibrillation or cardioversion shocks to patients, which can decrease quality of life, drain battery power, and potentially induce dangerous arrhythmias, due to inadequate arrhythmia classification techniques.
Innovation Solution
An implantable medical device (IMD) equipped with an electrode connector, data acquisition unit, R-wave detector, signal generator, impedance processor, and minimum detector that captures cardiac signals and cardiogenic impedance signals to classify arrhythmias based on the timing of R-waves and cardiogenic impedance minima, distinguishing between hemodynamically stable and unstable arrhythmias, and supraventricular and ventricular tachyarrhythmias.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional arrhythmia detection methods are used, then arrhythmias can be detected, but unnecessary shocks are delivered due to inadequate classification
Solution Approach 1:
The patent segments arrhythmia detection into multiple classification stages: first detecting potential arrhythmias using traditional methods, then applying additional classification criteria (impedance changes, R-wave characteristics, tachycardia morphology) to distinguish true ventricular arrhythmias from false positives such as supraventricular tachycardias with aberrant conduction. This multi-stage segmentation reduces unnecessary shocks while maintaining detection reliability.
Solution Approach 2:
The patent introduces impedance measurement as an intermediary parameter between traditional ECG detection and shock delivery decisions. By measuring impedance changes in the chest wall during tachycardia episodes, the system gains additional information to classify arrhythmia type more accurately before determining whether to deliver therapy, thereby reducing unnecessary shocks.
2Measurement precision
If multiple classification parameters are measured, then arrhythmia classification accuracy improves, but device complexity increases
Solution Approach 1:
The patent makes the impedance measurement system multi-functional: it serves both as a general safety feature for detecting lead disconnections and as a specific classification tool for distinguishing ventricular tachycardia from supraventricular tachycardia. This universal application of impedance measurement reduces the need for separate dedicated sensors, thereby limiting the increase in device complexity while improving classification accuracy.
Solution Approach 2:
The system uses existing ECG electrodes and signal processing circuits to generate impedance measurements without requiring entirely separate measurement systems. The same electrodes used for ECG detection serve dual purposes by also measuring impedance through the application of small test currents, allowing the device to self-serve multiple functions with existing components.
3Measurement precision
If extensive signal processing is performed, then classification accuracy improves, but energy consumption increases
Solution Approach 1:
The patent applies partial processing by selectively analyzing only the most discriminative features during tachycardia episodes. Rather than continuously processing all signal parameters, the system focuses computational resources on key classification criteria such as impedance change magnitude and R-wave morphology during suspected arrhythmia events, reducing overall energy consumption while maintaining classification accuracy.
Solution Approach 2:
The system performs extensive signal processing periodically during suspected arrhythmia episodes rather than continuously. Impedance measurements and advanced classification algorithms are activated only when tachycardia is detected, allowing the device to conserve energy during normal sinus rhythm while achieving high classification accuracy when it matters most for therapy decisions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The IMD effectively reduces unnecessary shocks by accurately classifying arrhythmias, allowing for appropriate treatment selection and minimizing battery depletion, thereby improving patient quality of life and device efficiency.
Implementation Method 1
A data acquisition unit of the IMD is connected to the electrode connector and configured to capture signals representative of the electric activity of at least a portion of the heart
Implementation Method 2
An impedance processor determines a cardiogenic impedance signal based on the generated and sensed electric signals
Data Source
AI summary
An implantable medical device, is designed to collect a signal representative of the electric activity of the heart and determine a cardiogenic impedance signal for at least a portion of the heart. An R-wave detector of the IMD detects the timing of an R-wave during a cardiac cycle based on the signal representative of the electric activity. A minimum detector detects the timing of a cardiogenic impedance minimum in the cardiogenic impedance signal and within a systolic time window of the cardiac cycle. A detected arrhythmia is then classified by the IMD based on the timing of the R-wave detected by the R-wave detector and the timing of the cardiogenic impedance minimum detected by the minimum detector.